Pooled analysis of the reports of carfilzomib, panobinostat, and elotuzumab combinations in patients with refractory/relapsed multiple myeloma

被引：0
作者：
Liping Liu
Ningning Zhao
Wenjun Xu
Zhixin Sheng
Lida Wang
机构：
[1] Weifang People’s Hospital,Department of Hematology
[2] Weifang People’s Hospital,E.N.T. Department
来源：
Journal of Hematology & Oncology | / 9卷
关键词：
Carfilzomib; Panobinostat; Elotuzumab; Multiple myeloma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 239 条
  • [41] Gravenor D(undefined)undefined undefined undefined undefined-undefined
  • [42] Eshaghian S(undefined)undefined undefined undefined undefined-undefined
  • [43] Nassir Y(undefined)undefined undefined undefined undefined-undefined
  • [44] Swift RA(undefined)undefined undefined undefined undefined-undefined
  • [45] Vescio RA(undefined)undefined undefined undefined undefined-undefined
  • [46] Niesvizky R(undefined)undefined undefined undefined undefined-undefined
  • [47] Martin TG(undefined)undefined undefined undefined undefined-undefined
  • [48] Bensinger WI(undefined)undefined undefined undefined undefined-undefined
  • [49] Alsina M(undefined)undefined undefined undefined undefined-undefined
  • [50] Siegel DS(undefined)undefined undefined undefined undefined-undefined
12345678910